World's Best Scientists 2026 revealed!
Christopher D.M. Fletcher

Christopher D.M. Fletcher

Award Badge
Best Scientists
2025

D-Index & Metrics

Best Scientists

D-Index
172
Citations
128527
World Ranking
803
National Ranking
484

Medicine

D-Index
176
Citations
134234
World Ranking
415
National Ranking
250

Christopher D.M. Fletcher publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Christopher D.M. Fletcher sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 753 publications — 84th percentile

84% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Christopher D.M. Fletcher D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Christopher D.M. Fletcher sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 176 D-Index — 98th percentile

98% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Research.com Recognitions

  • 2025 - Research.com Best Scientists Award

Overview

Christopher D.M. Fletcher was affiliated with Brigham and Women's Hospital in the United States. Their research work focused predominantly on medicine, with a significant number of publications within the subfields of pulmonary and respiratory medicine, rheumatology, oncology, pathology and forensic medicine, and surgery.

The scientist contributed extensively to the study and treatment of various tumor types and cancers. Key research topics in their body of work included:

  • Sarcoma diagnosis and treatment
  • Vascular tumors and angiosarcomas
  • Soft tissue tumor case studies
  • Urologic and reproductive health conditions
  • Lymphoma diagnosis and treatment
  • Bone tumor diagnosis and treatments
  • Cardiac tumors and thrombi

Christopher D.M. Fletcher authored numerous papers published in respected journals. Notable recent papers include:

  • "A Novel SS18-SSX Fusion-specific Antibody for the Diagnosis of Synovial Sarcoma," 2020, The American Journal of Surgical Pathology
  • "Ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities," 2021, Cancer
  • "Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts," 2021, ESMO Open
  • "Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology," 2020, PubMed
  • "Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor," 2023, Journal of Clinical Oncology

Their collaborative work frequently involved coauthors such as Jason L. Hornick, Brendan C. Dickson, David Papke, Lynette M. Sholl, and William J. Anderson, with whom they shared multiple publications.

Christopher D.M. Fletcher's research was published primarily in venues including:

  • The American Journal of Surgical Pathology
  • Modern Pathology
  • Histopathology
  • Blood
  • Laboratory Investigation

The scientist's work contributed to a substantial number of publications addressing challenging areas in medical research and clinical guidelines, highlighting an interdisciplinary approach spanning diagnostics, treatment protocols, and tumor pathology. Christopher D.M. Fletcher passed away, and their work remains a reference in multiple areas of oncologic and pathologic medicine.

Best Publications

  • Diagnosis of gastrointestinal stromal tumors: A consensus approach.

    Christopher D.M. Fletcher;Jules J. Berman;Christopher Corless;Fred Gorstein

  • Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors.

    George Daniel Demetri;Margaret von Mehren;Charles D. Blanke;Annick Diane Van Den Abbeele

  • Efficacy and safety of sunitinib in patients with advanced gastrointestinal stromal tumour after failure of imatinib: a randomised controlled trial

    George D Demetri;Allan T van Oosterom;Christopher R Garrett;Martin E Blackstein

  • PDGFRA Activating Mutations in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Anette Duensing;Laura McGreevey

  • Kinase Mutations and Imatinib Response in Patients With Metastatic Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Christopher L. Corless;George D. Demetri;Charles D. Blanke

  • Pazopanib for metastatic soft-tissue sarcoma (PALETTE): a randomised, double-blind, placebo-controlled phase 3 trial

    Winette T A Van Der Graaf;Jean Yves Blay;Sant P. Chawla;Dong Wan Kim

  • Phase III Randomized, Intergroup Trial Assessing Imatinib Mesylate At Two Dose Levels in Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing the Kit Receptor Tyrosine Kinase: S0033

    Charles D. Blanke;Cathryn Rankin;George D. Demetri;Christopher W. Ryan

  • Long-Term Results From a Randomized Phase II Trial of Standard- Versus Higher-Dose Imatinib Mesylate for Patients With Unresectable or Metastatic Gastrointestinal Stromal Tumors Expressing KIT

    Charles D Blanke;George D Demetri;Margaret von Mehren;Michael C Heinrich

  • Differentiation and reversal of malignant changes in colon cancer through PPARgamma.

    Pasha Sarraf;Elisabetta Mueller;Daniel Jones;Frederick J. King

  • KIT activation is a ubiquitous feature of gastrointestinal stromal tumors.

    Brian P. Rubin;Samuel Singer;Connie Tsao;Anette Duensing

  • Terminal Differentiation of Human Breast Cancer through PPARγ

    Elisabetta Mueller;Pasha Sarraf;Peter Tontonoz;Peter Tontonoz;Ronald M. Evans;Ronald M. Evans

  • NCCN Task Force report: management of patients with gastrointestinal stromal tumor (GIST)--update of the NCCN clinical practice guidelines.

    George D. Demetri;Robert S. Benjamin;Charles D. Blanke;Jean Yves Blay

  • The evolving classification of soft tissue tumours – an update based on the new 2013 WHO classification

    Christopher D M Fletcher

  • WHO classification of soft tissue tumours: an update based on the 2013 (4th) edition.

    Vickie Y. Jo;Christopher D.M. Fletcher

  • Inflammatory myofibroblastic tumor: comparison of clinicopathologic, histologic, and immunohistochemical features including ALK expression in atypical and aggressive cases.

    Cheryl M Coffin;Jason L Hornick;Christopher D M Fletcher

  • Molecular Correlates of Imatinib Resistance in Gastrointestinal Stromal Tumors

    Michael C. Heinrich;Christopher L. Corless;Charles D. Blanke;George D. Demetri

  • Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

    Michael C. Heinrich;Robert G. Maki;Christopher L. Corless;Cristina R. Antonescu

  • PD-L1 EXPRESSION IS CHARACTERISTIC OF A SUBSET OF AGGRESSIVE B-CELL LYMPHOMAS AND VIRUS-ASSOCIATED MALIGNANCIES

    Benjamin J. Chen;Bjoern Chapuy;Jing Ouyang;Heather H. Sun

  • Functional annotation of a full-length mouse cDNA collection

    J. Kawai;A. Shinagawa;K. Shibata;M. Yoshino

  • STI571 inactivation of the gastrointestinal stromal tumor c-KIT oncoprotein: biological and clinical implications

    David A. Tuveson;Nicholas A. Willis;Tyler Jacks;Tyler Jacks;James D. Griffin

Frequent Co-Authors

Jason L. Hornick
Jason L. Hornick Brigham and Women's Hospital
George D. Demetri
George D. Demetri Dana-Farber Cancer Institute
Jonathan A. Fletcher
Jonathan A. Fletcher Brigham and Women's Hospital
Paola Dal Cin
Paola Dal Cin Harvard Medical School
Cristina R. Antonescu
Cristina R. Antonescu Memorial Sloan Kettering Cancer Center
Fredrik Mertens
Fredrik Mertens Lund University
Thomas Mentzel
Thomas Mentzel Friedrich Schiller University Jena
Samuel Singer
Samuel Singer Memorial Sloan Kettering Cancer Center
Eduardo Calonje
Eduardo Calonje St Thomas' Hospital
Nils Mandahl
Nils Mandahl Lund University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring alternative pathways in healthcare can open doors to fulfilling careers beyond a traditional MD. Many students consider nursing programs due to flexible options and strong job prospects. For those looking to fast-track their careers, consider the cheapest direct entry msn programs available online for non-nurses. These programs allow career changers to quickly enter advanced nursing roles without prior nursing credentials.

Admission barriers can be a concern. If you are seeking accessible options, some of the easiest nursing programs to get into offer flexible entry requirements, making it simpler for applicants from diverse backgrounds to begin their journeys in nursing.

Beyond clinical care, medical billing and coding is a vital field that supports the healthcare industry. Those drawn to administrative or technical roles should consider medical billing and coding online schools that provide quality training with financial aid options.

Lastly, for prospective nursing students concerned about entrance exams, there are nursing schools that don't require teas or HESI exams, further broadening access to nursing education.

Best Scientists Citing Christopher D.M. Fletcher

Recently Published Articles